Redefining the role of Ca2+-permeable channels in photoreceptor degeneration using diltiazem

Das, Soumyaparna; Popp, Valerie; Power, Michael; Groeneveld, Kathrin; Yan, Jie; Melle, Christian; Rogerson, Luke; Achury, Marlly; Schwede, Frank; Strasser, Torsten; Euler, Thomas; Paquet-Durand, François; Nache, Vasilica

doi:10.1038/s41419-021-04482-1

Download PDF

Article
Open access
Published: 10 January 2022

Redefining the role of Ca²⁺-permeable channels in photoreceptor degeneration using diltiazem

Cell Death & Disease volume 13, Article number: 47 (2022) Cite this article

1892 Accesses
13 Citations
Metrics details

Subjects

Abstract

Hereditary degeneration of photoreceptors has been linked to over-activation of Ca²⁺-permeable channels, excessive Ca²⁺-influx, and downstream activation of Ca²⁺-dependent calpain-type proteases. Unfortunately, after more than 20 years of pertinent research, unequivocal evidence proving significant and reproducible photoreceptor protection with Ca²⁺-channel blockers is still lacking. Here, we show that both D- and L-cis enantiomers of the anti-hypertensive drug diltiazem were very effective at blocking photoreceptor Ca²⁺-influx, most probably by blocking the pore of Ca²⁺-permeable channels. Yet, unexpectedly, this block neither reduced the activity of calpain-type proteases, nor did it result in photoreceptor protection. Remarkably, application of the L-cis enantiomer of diltiazem even led to a strong increase in photoreceptor cell death. These findings shed doubt on the previously proposed links between Ca²⁺ and retinal degeneration and are highly relevant for future therapy development as they may serve to refocus research efforts towards alternative, Ca²⁺-independent degenerative mechanisms.

What colour are your eyes? Teaching the genetics of eye colour & colour vision. Edridge Green Lecture RCOphth Annual Congress Glasgow May 2019

Article Open access 23 August 2021

Reprogramming to recover youthful epigenetic information and restore vision

Article 02 December 2020

Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions

Article Open access 21 February 2023

Introduction

In the retina, rod photoreceptors respond to dim light and enable night-time vision, whereas cone photoreceptors respond to bright daylight and enable colour vision. Retinitis pigmentosa (RP) is a group of hereditary diseases where rod primary degeneration is followed by secondary cone loss, ultimately leading to blindness [1, 2]. Achromatopsia (ACHM) is a related disease where a genetic defect causes cone degeneration without significant rod loss [3]. Regrettably, most cases of RP/ACHM remain without effective treatment, even though photoreceptor death has been linked to overactivation of Ca²⁺-permeable channels [4, 5].

Phototransduction in rods and cones intricately links Ca²⁺- and cGMP-signalling. cGMP levels are regulated by guanylyl cyclase, producing cGMP, and phosphodiesterase-6 (PDE6), hydrolysing cGMP. In darkness, cGMP opens the cyclic nucleotide-gated channel (CNGC), located in the photoreceptor outer segment (OS), causing influx of Ca²⁺ and Na⁺ [6]. This influx is countered by the Na⁺-Ca²⁺-K⁺-exchanger (NCKX) in the OS and by the ATP-driven Na⁺-K⁺-exchanger (NKX) in the photoreceptor inner segment (IS) [6]. As a result, the cell is depolarised at approximately −35 mV [7]. The consequent activation of Ca_v1.4 (L-type) voltage-gated Ca²⁺-channels (VGCCs), located in the cell body and synapse, mediates further Ca²⁺ influx and synaptic glutamate release [7, 8]. In light, PDE6 rapidly hydrolyses cGMP, leading to CNGC closure, Ca²⁺ decrease, and photoreceptor hyperpolarization. Subsequently, VGCC closes, ending synaptic neurotransmitter release.

Loss-of-function mutations in PDE6 lead to cGMP accumulation and CNGC overactivation, disbalancing the cGMP feedback loop, which may result in an abnormally strong influx of Ca²⁺ into photoreceptor OSs [9, 10] and sustained activation of VGCCs, mediating even more Ca²⁺ influx [11]. In RP animal models, such as in the Pde6b mutant rd1 and rd10 mice [12], excessive Ca²⁺ is thought to lead to high activity of Ca²⁺-dependent calpain-type proteases and photoreceptor death [13, 14]. In rd1 animals the roles of CNGC and VGCC in photoreceptor cell death were studied by crossbreeding with knockouts (KO) of either CNGC (Cngb1^−/−) or VGCC (Cacna1f^−/−). While, VGCC KO did not influence rd1 degeneration [15], CNGC KO strongly delayed rd1 photoreceptor loss [16], highlighting CNGC as a target for pharmacological intervention.

Many studies over the past two decades have assessed the protective potential of Ca²⁺-channel blockers in photoreceptor degeneration (reviewed in [5]). The anti-hypertensive drug diltiazem is particularly interesting because its D-cis enantiomer blocks mostly VGCCs, while the L-cis enantiomer acts more strongly on CNGCs [17, 18]. Both D- and L-cis-diltiazem have been suggested to delay rd1 photoreceptor degeneration [11, 19, 20]. However, other studies reported conflicting or contradictory results [21,22,23].

Here, we assessed the effect of D- and L-cis-diltiazem on heterologously expressed rod and cone CNGCs. We show that L-cis-diltiazem efficiently reduces rod CNGC activity in a voltage- and cGMP-dependent manner, most probably by obstructing its conductive pore. Surprisingly, in retinal cultures, derived from rd1 and rd10 mice, neither D- nor L-cis-diltiazem prevented photoreceptor degeneration. Rather, CNGC inhibition with L-cis-diltiazem exacerbated photoreceptor loss. Together, our results indicate that CNGC or VGCC inhibition effectively reduces photoreceptor Ca²⁺ levels, however, this will not decrease, but may instead increase, photoreceptor degeneration.

Results

Differential effects of D- and L-cis-diltiazem on photoreceptor CNGC

To assess the effects of D- and L-cis-diltiazem on retinal CNGCs, we expressed the heterotetrameric rod CNGA1:B1a- and cone CNGA3:B3-channels in Xenopus laevis oocytes and examined their functional characteristics using electrophysiological recordings. We first confirmed correct assembly of heterotetrameric CNGC in the oocyte plasma membrane: (1) Co-expression of the main subunits, rod CNGA1 and cone CNGA3, with their modulatory subunits, CNGB1a and CNGB3, respectively, led to a strong increase of cAMP efficacy in heterotetrameric vs. homotetrameric channels [24, 25] (Fig. S1a, b). (2) Expression of CNGCs containing GFP-labelled CNGB1a or CNGB3 subunits and staining the oocyte membrane with fluorescently-labelled lectin (AlexaFluor^TM633-WGA) demonstrated plasma membrane localisation of heterotetrameric channels (Fig. S1b, e).

We measured next the CNGC concentration-activation relationships in the presence of cGMP (Table S1; Fig. S1c, f). Under physiological conditions, at −35 mV and with up to 5 µM cGMP [26], CNGC activity reached ~6% of its maximum for cones and ~1% for rods (Fig. 1a–d). When applied to the intracellular side of the membrane, neither D- nor L-cis-diltiazem (up to 100 µM) significantly influenced physiological CNGC activity (Fig. 1, Table S2). In the presence of saturating cGMP (3 mM), both diltiazem enantiomers inhibited cone and rod CNGCs (grey areas in Fig. 1a–d). The strongest effect on both CNGC isoforms was triggered by L-cis-diltiazem, while rod CNGC was more sensitive to both D- and L-cis-diltiazem (Fig. 1e, Table S2). While no direct measurements for cGMP in RP photoreceptors are available, the cGMP accumulation seen by immunostaining [9, 16] suggests a strong elevation of intracellular cGMP. We used 100 µM cGMP to emulate such a pathological situation and found that, the diltiazem effect on rod CNGCs mirrored closely our observations made in the presence of 3 mM cGMP (Fig. 1e, f).

**Fig. 1: Effects of D- and L-cis-diltiazem on rod and cone CNGC activity.**

Both diltiazem enantiomers (at 100 µM) showed a stronger inhibitory effect at depolarising (+100 mV) than at hyperpolarizing (−100 mV) membrane voltages: For D-cis-diltiazem by a factor of ~4 and ~7, and for L-cis-diltiazem by a factor of ~2.6 and ~1.4 in case of cone and rod CNGC, respectively (Figs. S2 and S3). In addition, we observed a voltage-dependent increase of the EC₅₀-values with a maximum at +100 mV and a systematic decrease of the H values at all tested voltages (Tables S1, S3 and Figs. S2, S3c, d). D- and L-cis-diltiazem showed similar effects on EC₅₀- and H values, suggesting that both diltiazem enantiomers reduced the CNGC apparent affinity and the cooperativity between their subunits through a similar mechanism.

In conclusion, (1) under physiological conditions, neither D- nor L-cis-diltiazem affected CNGC activity; (2) at saturating cGMP-concentration, diltiazem had a differential voltage-dependent effect, with a stronger inhibition of rod- vs. cone-CNGCs, the effect of L-exceeding that of D-cis-diltiazem, and with maximal inhibition at depolarising voltages.

Influence of D- and L-cis-diltiazem on CNGC gating kinetics

We then studied the influence of diltiazem on CNGC gating kinetics (Fig. 2a, b). When applying cGMP and diltiazem simultaneously, the inhibition occurred only after channel activation, suggesting that diltiazem blocked open channels only. When cGMP and diltiazem were simultaneously removed, the channel deactivation was considerably delayed, indicating that diltiazem hindered channel closure.

**Fig. 2: D- and L-cis-diltiazem influence on rod and cone CNGC gating kinetics.**

The activation time course of rod and cone CNGCs (τ_act) seemed unaffected by diltiazem, whereas the channel’s deactivation (τ_deact) was delayed and slowed down by a factor of ~2 (Fig. 2c, Table S4). Also, the kinetics of the blocking event was similar for both channel isoforms (τ_block). This suggested a common blocking mechanism for D- and L-cis-diltiazem, possibly by obstructing the CNGC pore. We next tested whether the observed diltiazem-induced block was Ca²⁺-dependent [27, 28]. In the presence of extracellular Ca²⁺ (1 mM CaCl₂) we found a reduced cGMP-triggered activation of CNGCs (Fig. S4a), an effect that was consistent with a very slow Ca²⁺ permeation [29]. Nevertheless, the influence of Ca²⁺ on the strength of the L-cis-diltiazem-induced block was only minor (Fig. S4b), indicating that Ca²⁺ did not prevent diltiazem binding to its binding pocket.

Influence of L-cis-diltiazem on cGMP binding

To assess whether diltiazem influences ligand binding, we employed confocal patch-clamp fluorometry (cPCF) [30, 31]. Here, we used rod CNGC, the most diltiazem-sensitive channel, L-cis-diltiazem, the enantiomer with the strongest blocking effect, and f*cGMP (8-[DY-547]-AHT-cGMP), a fluorescent derivative of cGMP (Fig. 3) [32]. As expected, the f*cGMP-induced current (10 µM) was reduced in the presence of L-cis-diltiazem to 10.8 ± 1.1%. Upon blocker removal from an open channel, the recovery of CNGC activity showed two steps with different kinetics: a fast and a very slow phase which took several minutes (Fig. 3). Surprisingly, this behaviour differed from the faster diltiazem washout observed when the blocker and cGMP were concomitantly removed (Fig. 2a, b). This indicated an acceleration of diltiazem unbinding triggered by simultaneous channel closure.

**Fig. 3: L-cis-diltiazem does not influence cGMP binding to rod CNGCs.**

During the application of L-cis-diltiazem and after its removal, we observed no major change in the intensity of the fluorescence signal which encodes for the total amount of bound f*cGMP to CNGCs (Fig. 3). This showed that L-cis-diltiazem inhibits CNGCs independent of cGMP binding, in line with our electrophysiological data on the channel’s apparent affinity (Fig. S3c, d).

Effects of D- and L-cis-diltiazem on light induced photoreceptor Ca²⁺ responses

We next recorded light-induced photoreceptor Ca²⁺-responses using two-photon imaging and transgenic mice expressing a fluorescent Ca²⁺-biosensor exclusively in cones [13]. As the biosensor was absent from OS, we recorded from cone terminals (Fig. 4a), using synaptic Ca²⁺ signals as a proxy for changes in membrane potential caused by light-dependent OS CNGC modulation [14]. We presented series of 1-s flashes of light and measured the change (decrease) in terminal Ca²⁺, quantifying the responses using area-under-the-curve (AUC), without (control) and with diltiazem enantiomers at 25, 50, and 100 µM concentrations.

**Fig. 4: Light-evoked Ca²⁺-responses are reduced by L-cis-diltiazem.**

We used a multivariate linear model to identify what factors (i.e., enantiomer, concentration) were significant for predicting cellular responses (Table S5). This analysis revealed that L-cis-diltiazem significantly decreased responses in a concentration-dependent manner, whereas D-cis-diltiazem did not affect light-induced cone Ca²⁺ responses (Fig. 4b–d; for detailed statistics, see Table S5). L-cis-diltiazem (but not D-cis-diltiazem) also tended to decrease the Ca²⁺-baseline level (Fig. 4b,c; left vs. right).

These data suggested that, at physiological cGMP concentrations, treatment with L-cis-diltiazem locked synaptic Ca²⁺ concentrations at a low level, abolishing cone light responses. D-cis-diltiazem, on the other hand, had no significant effect on light-induced Ca²⁺ responses in cones. Since in heterologously expressed CNGCs (Fig. 1) the rod channel isoform was more sensitive to L-cis-diltiazem than its cone counterpart, L-cis-diltiazem likely reduces rod Ca²⁺ levels even more.

Expression of CNGCs in photoreceptor outer segments

The effects of Ca²⁺-channel inhibitors on photoreceptor viability were tested using wild-type (wt) and rd1 mice. To ascertain that CNGC was expressed in rd1 retina in the relevant timeframe, we performed immunostaining for the CNGB1a channel subunit on retinal tissue sections collected at six different time-points between post-natal day (P) 11 and 30 (Fig. S5a–c). The CNGB1a staining was also used to estimate OS length (Fig. S5d). In wt retina OS length quadrupled between P11 and P30, while dramatically decreasing in rd1 retina in the same time window. As a proxy for photoreceptor degeneration, we measured the thickness of the outer nuclear layer (ONL), which contains the photoreceptor cell bodies, within a timeframe that includes most of the unfolding of rd1 photoreceptor degeneration (P11 to 30). Linear mixed effect models revealed statistically significant effects of genotype and post-natal day, showing significant differences for OS length between wt and rd1 with increasing age (Table S6). At the beginning of the rd1 degeneration (~P10), OS length as assessed by CNGB1a expression was still comparable to that in wt animals (average P11 OS length least square means difference between wt and rd1: 0.18 ± 2.05 µm, F (1, 25.25) = 0.0078; p = 0.9304). Hence, in rd1 retina the window-of-opportunity for CNGC-targeting treatments was expected to last until P11 at least.

Proteolytic activity in photoreceptors after treatment with D- and L-cis-diltiazem

The influx of Ca²⁺ through CNGCs may be connected to activation of Ca²⁺-dependent calpain-type proteases [33]. Therefore, we investigated the effects of D- and L-cis-diltiazem treatment, using an in situ calpain activity assay and immunodetection of activated calpain-2 [34], and organotypic retinal explant cultures derived from wt and rd1 animals, treated from P7 to P11.

In wt retina, least square means plot showed calpain activity and calpain-2 activation to be rather low, when compared to rd1 where both markers labelled large numbers of photoreceptors in the ONL (Fig. 5a–d). In both genotypes, treatment with D-cis-diltiazem had no detectable effect on the numbers of photoreceptors positive for calpain activity or calpain-2 activation (Fig. 5e–h and Tables S7, S8). Surprisingly, when retinal explants were treated with L-cis-diltiazem (Fig. 5i–l), photoreceptor calpain activity was significantly increased compared to control (F (1, 45) = 71.9711; p < 0.0001; Fig. 5i, k, m and Table S8). Similarly, calpain-2 activation in the ONL was also significantly increased with L-cis-diltiazem treatment (F (1, 11.87) = 14.7372; p = 0.0024; Fig. 5j, l, n and Table S8). Thus, neither D- nor L-cis-diltiazem reduced overall calpain activity in wt or rd1 photoreceptors, while a significant increase in calpain-2 activation was observed with L-cis-diltiazem (Fig. 5m, n and Tables S7, S8).

**Fig. 5: Effects of diltiazem treatment on calpain activity.**

Activity of caspase-type proteases is commonly associated with apoptosis. To investigate possible links with apoptosis, rd1 treated and untreated retinas were tested for activation of caspase-3, using an antibody directed against the active protease [35]. Under all conditions tested, caspase-3 activity was essentially undetectable in retinal sections (Fig. S6 and Table S7), thus ruling out an important contribution of caspase activity and, by extension, of apoptosis to retinal degeneration, with or without diltiazem treatment.

Impact of D- and L-cis-diltiazem on rd1 photoreceptor degeneration

We used the TUNEL assay to quantify photoreceptor cell death [36] after D- or L-cis-diltiazem treatment on organotypic retinal explant cultures derived from wt, rd1, and rd10 animals [33]. The ONL of wt retinal explants displayed a relatively low number of TUNEL positive cells, when compared to rd1 (Fig. 6a, b). D-cis-diltiazem treatment did not elevate the numbers of dying cells in wt or rd1 ONL (Fig. 6c, d). In contrast, L-cis-diltiazem (Fig. 6e, f) increased cell death in both wt (F (1, 21.63) = 86.7207, p < 0.0001) and rd1 retina (F (1, 26.68) = 191.1994, p < 0.0001; Fig. 6g, h and Tables S7, S8).

**Fig. 6: Effects of D- and L-cis-diltiazem on retinal cell viability.**

Typically, TUNEL positive cells in untreated retinal explants were uniformly distributed across the whole ONL (Fig. 6a, b; percent rd1 dying cells in inner half of ONL = 60 ± 3%). With D-cis-diltiazem treatment 57 ± 4% of dying cells were localised to the same space (Fig. 6c, d), while, curiously, with L-cis-diltiazem treatment 85 ± 3% (F (1, 10.42) = 54.2025, p < 0.0001; Tables S7, S8) of the TUNEL positive cells were seen in the lower ONL half (Fig. 6e, f, i). A study on rd10 retina yielded results similar to rd1: 100 µM D-cis-diltiazem had no significant effect on cell death, while 100 µM L-cis-diltiazem treatment caused a strong increase in photoreceptor cell death (F (1, 9.25) = 42.9966, p < 0.0001; Fig. 6j).

In parallel to the assessment of cell death, we also tested whether the treatment with diltiazem would affect the accumulation of cGMP in rd1 photoreceptors. Even though there was a trend towards a higher number of cGMP photoreceptors in L-cis diltiazem treated rd1 retina, this effect did not attain statistical significance (Fig. S7).

Taken together, our data indicate that L-cis-diltiazem treatment in wt retina was toxic to photoreceptors at concentrations above 25 µM. rd1 retina showed such toxicity only at concentrations above 50 µM, which might be related to higher photoreceptor cGMP levels and concomitant higher CNGC activity. In comparison, D-cis-diltiazem, up to 100 µM, did not detectably influence cell viability in either wt-, rd1-, or rd10- retinas. Importantly, both diltiazem enantiomers failed to show protective effects in rd1 or rd10 mutant retina.

Discussion

We show that diltiazem enantiomers were highly effective at blocking photoreceptor Ca²⁺ influx through CNGCs at pathologically high cGMP concentrations, likely by blocking the channel’s pore. Unexpectedly, this block did not result in photoreceptor protection. These results raise the question whether Ca²⁺-permeable channels are suitable targets for therapeutic interventions, and furthermore suggest that high intracellular Ca²⁺ is not per se a driver of photoreceptor death.

Effect of D- and L-cis-diltiazem on photoreceptor CNGCs

At physiological cGMP, neither D- nor L-cis-diltiazem showed an appreciable inhibitory effect on heterologously expressed CNGCs. At RP-like, high cGMP concentrations, both diltiazem enantiomers reduced rod and cone CNGC activity, although L-cis-diltiazem had a much stronger inhibitory effect on rod CNGC than D-cis-diltiazem. The inhibition was strongly voltage dependent, suggesting that a disease-induced photoreceptor depolarisation would amplify diltiazem effects on CNGCs. Although electrophysiological recordings from single photoreceptors of retinal disease models are rare [37], rd1 rod photoreceptors can be expected to be permanently depolarised due to elevated CNGC activity triggered by high cGMP.

Earlier studies on photoreceptor CNGC proposed several binding sites for diltiazem, either at the pore entrance, on the cytoplasmic side of the channel [38], or within the channel pore [39]. Recently, diltiazem was shown to bind within the conductive pathway of voltage-gated Ca²⁺-channels (Ca_vAb and Ca_v1.1) [40, 41]. Our data on CNGC, e.g., (1) the time delay observed between channel activation and diltiazem block and between diltiazem removal and channel closure, (2) the acceleration of diltiazem removal by a concomitant channel deactivation, and (3) the undisturbed cGMP binding in the presence of diltiazem, suggests that L-cis-diltiazem acts in a similar way, by blocking the CNGC pore. These findings indicate an open-channel block and concur with the recent eukaryotic [42] and human CNG [43] cryo-EM channel structures.

Moreover, we observed a negative influence of diltiazem on the cooperativity between CNGC subunits. Since L-cis-diltiazem inhibits only heterotetrameric channels [25], this suggests a direct interaction between diltiazem and the modulatory subunits, rod CNGB1a and cone CNGB3, respectively. Future studies using molecular-docking approaches may help identify the diltiazem binding site within the channel’s pore and its biophysical characteristics.

An overview on Ca²⁺ flux in photoreceptor degeneration

Photoreceptor degeneration in hereditary retinal diseases has long been proposed to be caused by excessive Ca²⁺ influx [10, 19], i.e. the “high Ca²⁺ hypothesis”. Paradoxically, too low Ca²⁺ was also suggested to cause photoreceptor death, something that may be called the “low Ca²⁺ hypothesis” [44]. Subsequently, we discuss Ca²⁺ flux in different photoreceptor compartments (Fig. 7a) and will attempt to resolve some of the contradictions between high and low Ca²⁺ hypotheses.

**Fig. 7: Schematic representation of photoreceptor Ca²⁺ flux under different experimental conditions.**

In wt photoreceptors, under dark conditions, Ca²⁺ and Na⁺ enter the OS (Fig. 7b). While Ca²⁺ is extruded from the OS via NCKX, Na⁺ is actively exported by ATP-dependent NKX in the IS [45]. In cell body and synapse, Ca²⁺ is extruded by the plasma membrane Ca²⁺-ATPase (PMCA) [46]. During illumination, cGMP levels drop, CNGCs and then VGCCs close, and Ca²⁺ levels in OS and synapse decrease (Fig. 7c). In rd1 retina, the constitutively open CNGCs allow for permanent Ca²⁺ and Na⁺ influx, increasing NKX activity and perhaps resulting in ATP depletion (Fig. 7d) [47]. L-cis diltiazem will block CNGC, reducing Ca²⁺ influx into the OS (Fig. 7e). D-cis-diltiazem in turn blocks mostly VGCC and prevents Ca²⁺ influx into cell body and synapse (Fig. 7f).

Surprisingly, calpain-2 activation was increased by the L-cis-diltiazem treatment. At this point we can only speculate that this may have been caused by a depletion of Ca²⁺ in intracellular stores and a subsequent activation of store-operated Ca²⁺ entry (SOCE) via Ca²⁺ release-activated Ca²⁺ channels (CRACs) [48]. Indeed, VGCC block with diltiazem was recently shown to activate SOCE in vascular smooth muscle cells [49] and this process may selectively activate calpain-2 [50]. Moreover, there is at least indirect evidence for SOCE occurring when photoreceptor Ca²⁺ has become depleted [51]. Thus, photoreceptor degeneration initially caused by very low Ca²⁺ levels, may trigger a consequent increase of Ca²⁺ and calpain-2 activity via SOCE, possibly explaining the apparent contradiction between high and low Ca²⁺ hypotheses. Moreover, low photoreceptor Ca²⁺ levels will disinhibit guanylyl cyclase, increasing cGMP production [52], which may then kill photoreceptors independent of Ca²⁺ via over-activation of cGMP-dependent protein kinase G (PKG) [53, 54]. Future studies may reveal what substrate(s) of PKG may mediate photoreceptor cell death [55].

Calpain activity, Ca²⁺, and cell death

Previously, we had proposed calpain activation in dying photoreceptors to be mediated by high cGMP-activated CNGCs [33]. However, the low mobility of Ca²⁺ ions from OS to IS [13, 56, 57] argues against CNGC-dependent Ca²⁺-influx directly activating calpain in the cell body and beyond. Instead, our data suggests that calpain activation may be mediated indirectly by Ca²⁺ influx via VGCC located in cell body and synapse, in line with data obtained from genetic inactivation of VGCC [15].

L-cis-diltiazem was highly effective at blocking Ca²⁺ influx in heterologously-expressed rod CNGC and displayed a good rod vs. cone CNGC selectivity. When rd1 retina was treated with L-cis-diltiazem, rod CNGCs were expressed in photoreceptors during the treatment period. Yet, we were unable to demonstrate a protective effect of L-cis-diltiazem on rd1 retina. Even worse, at higher concentrations, L-cis-diltiazem showed obvious signs of toxicity, in wt, rd1, and rd10 retina. This is contradicting the results seen with genetic inactivation of CNGC in rd1 * Cngb1^−/− double-mutant mice [9]. Yet, such animals likely still retain CNGA1 homotetrameric channels, which may allow for limited Ca²⁺ influx into the photoreceptor [58]. In addition, loss-of-function mutations in CNGC genes are known to cause photoreceptor degeneration in both RP [59] and ACHM [60]. Hence, on a genetic level, low activity of CNGC and decreased Ca²⁺ influx into photoreceptor OSs is clearly connected to photoreceptor degeneration.

Incidentally, inhibition of VGCC with D-cis-diltiazem also failed to show significant photoreceptor protection. This is in line with a number of earlier studies (reviewed in [5]) and corroborates on a pharmacological level our previous study employing the rd1 * Cacna1f^−/− double-mutants, i.e. rd1 mice in which the synaptic VGCC was dysfunctional [15]. In contrast to L-cis-diltiazem, D-cis-diltiazem did not appear to be overly retinotoxic even at high concentrations. This corresponds to the genetic situation where loss-of-function mutations in VGCC impair synaptic transmission from photoreceptors to second order neurons. While such mutations can cause night-blindness, they do not usually cause photoreceptor degeneration [61].

Excessive Ca²⁺ influx via CNGC and/or VGCC has for a long time been suggested as a major driver for photoreceptor cell death [9, 19]. However, follow-up studies have produced contradictory results [5]. Our present study sheds light onto this enigma and demonstrates that both D- and L-cis enantiomers of the anti-hypertensive drug diltiazem can reduce photoreceptor Ca²⁺ influx. Remarkably, treatment with either compound and inhibition of either VGCC or CNGC did not result in photoreceptor protection. Moreover, the use of L-cis-diltiazem and the concomitant reduction of Ca²⁺ influx strongly reduced photoreceptor viability, indicating that Ca²⁺-influx was in fact protective, rather than destructive. Altogether, this supports the “low Ca²⁺” hypothesis [44] and cGMP-dependent processes [54] as the more likely causes of photoreceptor degeneration.

Materials and methods

Animals

Animals used in this study were handled according to the German law on animal protection. All efforts were made to keep the number of animals used and their suffering to a minimum. Mice were bred in the Tübingen Institute for Ophthalmic Research specified-pathogen-free (SPF) housing facility, under 12 h/12 h light/dark cycle, had ad libitum access to food and water, and were used irrespective of gender. The experimental procedures involving animals were reviewed and approved by the institutional animal welfare committee of the University of Tübingen.

For retinal explant cultures C3H/HeA Pde6b^rd1/rd1 animals (rd1) and their respective congenic wild-type C3H/HeA Pde6b^+/+ counterparts (wt) were used [62]. Further studies were performed on explants derived from C57BL/6 J Pde6b^rd10/rd10 animals (rd10) [33]. For studying light-induced Ca²⁺ responses in cone photoreceptors, we used transgenic mice expressing the Ca²⁺ biosensor TN-XL [63] under the human red opsin promoter HR2.1 on a C57BL/6 J background [13].

The procedures regarding the Xenopus laevis frogs and the handling of the oocytes had approval from the authorised animal ethics committee of the Friedrich Schiller University Jena (Germany). The respective protocols were performed in accordance with the approved guidelines.

Molecular biology and functional expression of heterotetrameric CNGCs in Xenopus laevis oocytes

The coding sequences for the retinal CNGC subunits, bovine CNGA1 (NM_174278.2) [64] and CNGB1a (NM_181019.2) [65] from rod photoreceptors and human CNGA3 (NM_001298.2) [66] and CNGB3 (NM_019098.4) [67] from cone photoreceptors, were subcloned into the pGEMHE vector [68] for heterologous expression in Xenopus laevis oocytes. The degree of CNGC-sequence identity across the three species involved in this study (Homo sapiens, Bos taurus, and Mus musculus) was between ~69 and 91%.

The surgical removal of oocytes was performed from adult frog females under anaesthesia (0.3% tricaine; MS-222, Pharmaq Ltd., Fordingbridge, UK). The oocytes were treated with collagenase A (3 mg/ml; Roche Diagnostics, Mannheim, Germany) for 105 min in Barth’s solution containing (in mM) 82.5 NaCl, 2 KCl, 1 MgCl₂, and 5 HEPES, pH 7.5. After this procedure, oocytes of stages IV and V were manually dissected and injected with the genetic material encoding for the CNGC from rod and cone photoreceptors. For efficient generation of heterotetrameric channels, the ratio of CNGA3 mRNA to CNGB3 mRNA was 1:2.5 [25] and of CNGA1 mRNA to CNGB1a mRNA was 1:4 [69]. After injection, the oocytes were kept at 18 °C for 2 to 7 days in Barth’s solution containing (in mM) 84 NaCl, 1 KCl, 2.4 NaHCO₃, 0.82 MgSO₄, 0.41 CaCl₂, 0.33 Ca(NO₃)₂, 7.5 Tris, cefuroxime (4.0 µg × ml⁻¹), and penicillin/streptomycin (100 µg × ml⁻¹), pH 7.4.

Electrophysiology

Macroscopic ionic currents were measured with the patch-clamp technique and the inside-out configuration, using an Axopatch 200B patch-clamp amplifier (Axon Instruments, Foster City, CA). Recordings were made at room temperature. Current data were acquired using PATCHMASTER software (HEKA Elektronik, Lambrecht, Germany) with a sampling frequency of 5 kHz, and low-pass filtered at 2 kHz. From a holding potential of 0 mV, currents were elicited by voltage steps to −65 mV, then to −35 mV, and back to 0 mV. When mentioned, also voltage steps to −100 mV and +100 mV were recorded. The patch pipettes were pulled from borosilicate glass tubing (outer diameter 2.0 mm, inner diameter 1.0 mm; Hilgenberg GmbH, Germany). The initial resistance was 0.6–1.3 MΩ. Intracellular and extracellular solutions contained 140 mM NaCl, 5 mM KCl, 1 mM EGTA, and 10 mM HEPES (pH 7.4). The Ca²⁺-containing solutions were: 120 mM NaCl, 3 mM KCl, 2 mM NTA, 0.5 mM niflumic acid, 10 mM HEPES and 1 mM CaCl₂ (pH 7.4) for the extracellular side and 145 mM KCl, 8 mM NaCl, 2 mM NTA, 10 mM HEPES and 0.05 mM CaCl₂ (pH 7.4) for the intracellular side [28].

The cyclic nucleotides, cAMP (Merck KGaA, Darmstadt, Germany) or cGMP (Biolog LSI GmbH & Co KG, Bremen, Germany), were added to intracellular solutions as indicated. Either D- or L-cis-diltiazem (Abcam - ab120260 and Abcam - ab120532, respectively, Germany) were added to the cGMP-containing solutions to a final concentration of 25 µM and 100 µM as required. The diltiazem-containing solutions were prepared from stock solutions (10 mM) immediately before experiments. The cGMP-solutions, or solution mixtures containing cGMP and either D- or L-cis-diltiazem were administered via a multi-barrel application system to the cytosolic face of the patch.

For studying CNGC activation and deactivation kinetics we performed fast solution jumps (from zero to either 3 mM cGMP or 3 mM cGMP + 100 μM D- or L-cis-diltiazem and back to zero) by means of a double-barrelled θ-glass pipette mounted on a piezo-driven device [70]. The recording rate was 20 Hz. The solution exchange at the pipette tip was completed within 1 ms [71].

Confocal patch-clamp fluorometry (cPCF)

The influence of D- and L-cis-diltiazem on cGMP binding was studied by means of cPCF. The method has been described in detail previously [31, 72, 73]. The experiments were performed in inside-out macropatches of Xenopus laevis oocytes expressing heterotetrameric rod CNGC, at −35 mV. As fluorescent ligand we used 8-[DY-547]-AHT-cGMP (f*cGMP). f*cGMP was prepared in analogy to the related cyclic nucleotides 8-[DY-547]-AET-cGMP and 8-[DY-547]-AHT-cAMP [31, 32]. To be able to differentiate between the fluorescence of the bound f*cGMP from the fluorescence generated by the free f*cGMP in the bath solution, we used an additional red dye, DY647 (Dyomics, Jena, Germany), at a concentration of 1 µM.

Recordings were performed with an LSM 710 confocal microscope (Carl Zeiss Jena GmbH, Germany) and were triggered by the ISO3 hard- and software (MFK, Niedernhausen, Germany; sampling rate 5 kHz, 4-pole Bessel filter set to 2 kHz). Due to the relative long duration of the experiment, to avoid cell-membrane exposure to damaging amounts of light, binding was measured under steady-state conditions, during pre-selected time windows only: in the presence of 10 µM f*cGMP, during the jump to 10 µM f*cGMP + 100 µM L-cis-diltiazem and during L-cis-diltiazem removal from the open channels.

Colocalization experiments

To verify the correct incorporation of heterotetrameric CNGCs into the oocyte plasma membrane we labelled the cone CNGB3- and rod CNGB1a-subunit by fusing enhanced GFP to their intracellularly located C terminus. At first, we introduced an AvrII site in pGEMHE-CNGB1a by site-directed mutagenesis at CNGB1a K1205 which was thereby changed to R1205. Afterwards, the PCR amplified EGFP gene was ligated into the newly generated AvrII site of the pGEHME-CNGB1a construct. To fuse EGFP into CNGB3 C-terminus, we introduced an XhoI site in pGEMHE-CNGB3 by site-directed mutagenesis at CNGB3 P668 and K669 which were thereby changed to L668 or E669, respectively. Afterwards, the PCR amplified EGFP gene was ligated into the newly generated XhoI site of the pGEHME-CNGB3 construct. The correct insertion of PCR products was confirmed by DNA sequencing.

The oocyte membrane was stained from the extracellular side with fluorescently labelled lectin (Alexa Fluor^TM 633 - wheat germ agglutinin (Alexa-WGA), Invitrogen Life Technologies Corporation, Eugene, Oregon, red fluorescence signal) [73]. For this the oocytes were incubated in 5 µg/ml Alexa-WGA for 7 min. Alexa-WGA was excited with the 633-nm line of a helium neon laser. GFP was excited with the 488-nm line of an argon laser. GFP- and WGA-fluorescence profiles measured along an imaginary line perpendicular to the plasma membrane, were quantified using the LSM 710 image analysis software.

Analysis of the oocyte data

For concentration-activations relationships, each patch was first exposed to a solution containing no cGMP and then to a solution containing the saturating concentration of 3 mM cGMP. After subtracting the baseline current from the current amplitude in the presence of cGMP, the current response for each ligand concentration was normalised to the saturating current. The experimental data points were fitted using the Hill equation:

$$\frac{I}{{I_{max}}} = \frac{1}{{1 + \left( {\frac{{EC_{50}}}{x}} \right)^H}}$$

(1)

where I is the current amplitude, I_max is the maximum current induced by a saturating cGMP concentration, x is the ligand concentration, EC₅₀ is the ligand concentration of half maximum effect, and H is the Hill coefficient. The analysis was performed with OriginPro 2016G software (OriginLab Corporation, Northampton, USA). Experimental data are given as mean ± SEM.

The effect of either D- or L-cis-diltiazem was quantified by measuring the cGMP-induced current, under steady-state conditions at the end of either −100 mV, −35 mV, or +100 mV pulse, in the presence of diltiazem as required. The amount of diltiazem block (%) is related to the current at the respective cGMP concentration and the amount of current decrease in the presence of diltiazem and was calculated as follow (here exemplified for the 100 µM cGMP-induced current):

$$diltiazem\,block\left( {{{\mathrm{\% }}}} \right) = 100 - \frac{\displaystyle{\frac{{I_{(100{{{\mathrm{\mu }}}}M\,cGMP + x\,{{{\mathrm{\mu }}}}M\,Diltiazem)}}}{{I_{(3mM\,cGMP + x\,{{{\mathrm{\mu }}}}M\,Diltiazem)}}} \cdot 100}}{\displaystyle{\frac{{I_{(100{{{\mathrm{\mu }}}}M\,cGMP)}}}{{I_{(3mM\,cGMP)}}}}}$$

(2)

The time courses for channel activation, deactivation (starting after the respective initial delay due to diltiazem removal) and diltiazem block were fitted with a single exponential:

$$I\left( t \right) = A \ast exp\left[ {\frac{{ - t}}{\tau }} \right]$$

(3)

where A is the amplitude, t the time, and τ the time constant for either activation, deactivation, or block.

The time course for diltiazem washout was fitted with a double-exponential function:

$$I\left( t \right) = A_1 \ast exp\left[ {\frac{{ - t}}{{\tau _{fast}}}} \right] + A_2 \ast exp\left[ {\frac{{ - t}}{{\tau _{slow}}}} \right] + y_0$$

(4)

where A₁,A₂ are the amplitudes of the fast and slow components, t the time, and τ_fast and τ_slow the time constants for the fast and slow phase of the diltiazem washout.

For statistical analysis of D- and L-cis-diltiazem effect on retinal CNGCs, we used the two-tailed unpaired Student t-test. Figures were prepared using CorelDraw X7 (Corel, Ottawa, Canada).

Retinal explant culture

To assess the effects of D- and L-cis-diltiazem on calpain activity and photoreceptor degeneration, rd1 retinas were explanted at post-natal day (P) 5, while retinas from more slowly degenerating rd10 animals were explanted at P9. The explants were cultured on a polycarbonate membrane (Corning-Costar Transwell permeable support, 24 mm insert, #CLS3412) with complete medium (Gibco R16 medium with supplements) [74]. The R16 medium was exchanged every two days with treatment added at either P7 and P9, for rd1, or at P11, P13, P15 for rd10 explants. The cultures were treated with 25, 50, and 100 µM of D- and L-cis-diltiazem, respectively. Cultures were ended on P11 (rd1) and P17 (rd10) by fixing the cultures with 4% paraformaldehyde (PFA). The explants were embedded in Tissuetek (Sakura Finetek Europe B.V.) and sectioned (12 µm) in a cryostat (ThermoFisher Scientific, CryoStar NX50 OVP, Runcorn UK).

TUNEL staining

The TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labelling) assay kit (Roche Diagnostics, Mannheim, Germany) was used to label dying cells. Histological sections from retinal explants were dried and stored at −20 °C. The sections were rehydrated with phosphate-buffered saline (PBS; 0.1 M) and incubated with Proteinase K (1.5 µg/µl) diluted in 50 mM TRIS-buffered saline (TBS; 1 µl enzyme in 7 ml TBS) for 5 mins. This was followed by 3 times 5 min TBS washing and incubation with a mixture of 30% HCl and 70% ethanol for 5 min to increase the accessibility of cells to the enzyme. Another 3 times 5 min washing was followed by incubation with blocking solution (10% normal goat serum, 1% bovine serum albumin, 1% fish gelatine in phosphate-buffered saline with 0.03% Tween-20). TUNEL staining solution was prepared using 10 parts of blocking solution, 9 parts of TUNEL labelling solution and 1 part of TUNEL enzyme. After blocking, the sections were incubated with TUNEL staining solution overnight at 4 °C. Finally, the sections were washed 2 times with PBS, mounted using Vectashield with DAPI (Vector Laboratories Inc, Burlingame, CA, USA) and imaged under a Zeiss (ApoTome.2) microscope for further analysis.

Calpain-activity assay

This assay allows resolving overall calpain activity in situ, on unfixed tissue sections [14]. Retinal tissue sections were incubated and rehydrated for 15 min in calpain reaction buffer (CRB) (5.96 g HEPES, 4.85 g KCl, 0.47 g MgCl₂, 0.22 g CaCl₂ in 100 ml ddH₂O; pH 7.2) with 2 mM dithiothreitol (DTT). The tissue sections were incubated for 2 h at 37 °C in CRB with tBOC-Leu-Met-CMAC (5 µM; Thermofisher Scientific, A6520). Afterwards, the tissue sections were washed twice in PBS (5 min) and mounted using Vectashield mounting medium (Vector) for immediate visualisation under the ZEISS ApoTome2.

Immunohistochemistry

The cryo-sectioned slides were dried for 30 min at 37 °C and hydrated for 15 min. The sections were then incubated with blocking solution (10% NGS, 1% BSA and 0.3% PBST) for one hour. The primary antibodies CNGB1 (Sigma–Aldrich, HPA039159; 1:1000), calpain-2 (Abcam, ab39165; 1:300), caspase-3 (Cell Signalling, 9664; 1:1000), or cGMP (kind gift from Prof. Harry Steinbusch, Maastricht University, The Netherlands; 1:250) were diluted in blocking solution and incubated overnight at 4 °C. Rinsing with PBS for 3 times 10 min each was followed by incubation with secondary antibody (Molecular Probes, AlexaFluor488 (A01134) or AlexaFluor562 (A11036), diluted 1:500 in PBS) for one hour. The sections were further rinsed with PBS for 3 times 10 min each and mounted with Vectashield containing DAPI (Vector).

Microscopy and image analysis in retinal cultures

The images of ex vivo retina and organotypic explant cultures were captured using a Zeiss Imager Z.2 fluorescence microscope, equipped with ApoTome2, an Axiocam 506 mono camera, and HXP-120V fluorescent lamp (Carl Zeiss Microscopy, Oberkochen, Germany). The excitation ($\lambda _{Exc.}$)/emission ($\lambda _{Em.}$) characteristics of the filter sets used for the different fluorophores were as follows (in nm): DAPI ($\lambda _{Exc.} = 369\,nm$, $\lambda _{Em.} = 465\,nm$), AF488 ($\lambda _{Exc.} = 490\,nm$, $\lambda _{Em.} = 525\,nm$), and AF562 ($\lambda _{Exc.} = 578\,nm$, $\lambda _{Em.} = 603\,nm$). The Zen 2.3 blue edition software (Zeiss) was used to capture images (both tiled and z-stack, 20x magnification). The data were collected from 7 to 9 different sections obtained from 3 to 5 animals. Sections of 12 µm thickness were analysed using 8–12 Apotome Z-planes. The positive cells in the ONL were manually quantified, the ONL area was measured in Zen 2.3 software. The total number of cells in the ONL was calculated using an average cell (nucleus) size and the percent positive cells was determined with respect to the total number of cells in the same ONL area. Values were normalised to control condition (100%).

The relative localisation of positive cells within the ONL was assessed by dividing the width of the ONL horizontally into two equal halves (i.e. upper and lower half) and manually quantifying the distribution of positive cells in each of the halves. The chance level for cell distribution was 50%. The percent of degenerating photoreceptors localised close to OPL, were analysed by comparing cell count in the lower half of ONL to total positive cells in the ONL.

Statistical analysis for retinal cultures

Linear mixed-effects models were fitted by restricted maximum likelihood estimation (REML), to assess the significance of the effects in explaining the variations of the dependent variables. Variance inflation factors (VIF) of the predictor variables were calculated and assured to fall well below the common threshold value, indicating no collinearity between them [75]. The residuals were confirmed visually to follow a normal distribution, while homoscedasticity (homogeneity of the residual variances) was tested using the Brown–Forsythe test [76] and reported in case of violations.

Figures were prepared using Photoshop CS5 (Adobe, San Jose, CA, USA). Statistical analysis and graph preparation were performed using JMP 15.2.0 (466311, SAS Institute Inc, Cary, NC, USA).

Two-photon Ca²⁺ imaging

Light stimulus-evoked Ca²⁺ responses were recorded in cone axon terminals using a two-photon (2 P) microscope, as previously described [77]. In brief, we used adult transgenic HR2.1:TN-XL mice (for details, see above). After dark adaptation for ≥1 h [13], the animal was deeply anaesthetised with isoflurane (CP-Pharma, Germany), and then sacrificed by cervical dislocation. All procedures were performed under dim red illumination. Following enucleation of the eyes, the retinas were dissected and vertically sliced (~200 µm) in artificial cerebral spinal fluid (ACSF), which contained (in mM): 125 NaCl, 2.5 KCl, 2 CaCl₂, 1 MgCl₂, 1.25 NaH₂PO₄, 26 NaHCO₃, 0.5 L-glutamine, and 20 glucose (Sigma–Aldrich or Merck, Germany) and was maintained at pH 7.4 with carboxygen (95% O₂, 5% CO₂). Next, the slices were transferred to the 2 P microscope’s recording chamber and superfused with warmed (37 °C) ACSF.

The 2P microscope, a customised MOM (Sutter Instruments, Novato, USA [78]) was driven by a mode-locked Ti:Sapphire laser (MaiTai-HP DeepSee; Newport Spectra-Physics, Darmstadt, Germany) tuned to 860 nm. For further technical details on the 2 P setup configuration, see [77]. TN-XL is a ratiometric FRET-based Ca²⁺ indicator [63], therefore we used two detection channels with the appropriate band-pass (BP) filters (483 BP 32; 535 BP 50; AHF, Tübingen, Germany) to capture both the sensor’s donor (F_D; ECFP) and acceptor fluorescence (F_A; citrine) simultaneously. The relative Ca²⁺ level in the cone terminals was then represented by the ratio F_A/F_D (cf. Fig. 4b, c). Light stimuli were presented using a custom-built stimulator [79] with two band-pass filtered LEDs (UV filter: 360 BP 12; green: 578 BP 10; AHF) mounted below the recording chamber.

Before presenting light flashes and recording cone Ca²⁺ signals, slices were adapted to a constant background illumination equivalent to a photoisomerisation rate of ~10⁴P*/cone s⁻¹ for ≥15 s. Light stimuli consisted of a series of 1-s bright flashes at 0.25 Hz, evoking similar photoisomerisation rates (~6.5·10³P*s⁻¹/cone) in both mouse cone types.

Stock solutions (100 mM) of D- and L-cis-diltiazem were prepared in distilled water and stored at 4 °C. Prior to each experiment, D- or L-cis-diltiazem dilutions were freshly prepared from the stock in carboxygenated ACSF solution. For bath application, the tissue was perfused with D- or L-cis-diltiazem (25, 50, or 100 µM) added to the bathing solution for ≥1 min before commencing the recording; the perfusion rate was of ~1.5 ml/min. Drug entry into the recording chamber was confirmed by adding Sulforhodamine 101 (Sigma–Aldrich) to the drug solution.

Analysis of Ca²⁺-imaging data

To identify the factors (i.e. L-cis vs. D-cis, concentration) that are significant for predicting the response of a cell during drug treatment (a potential change in AUC), we applied a multivariate linear model [80]. The importance of each factor was estimated as its impact on the predictive power of the statistical model. The effect of each factor was considered both individually and in interactions with the other variables, to identify which factor or group of factors is best at modelling the AUC values. The explanatory variables were standardised prior to model fitting, by subtracting the mean and dividing by the standard deviation of the variable. As before, the statistical assumptions of the linear model were evaluated. The VIF for each explanatory variable was found to fall below the common threshold, indicating a lower level of multicollinearity. Visual inspection showed that the residuals were approximately normally distributed. A Brown-Forsythe test indicated that there was heteroscedasticity in the data, though as previously noted these models are robust to such variability. The model also incorporated a random effects term for the recording field, which controlled for recordings where the ROIs were on average higher or lower than the mean across all ROIs in all recordings. Specifically, the modelling showed that (1) more active cells (higher AUC) were more sensitive to the drug application, (2) there was a statistically significant difference between the effects of L- and D-cis- diltiazem on the AUC, and (3) the drug concentration also had a significant effect on AUC.

The effect size is determined using the method for estimating semi-partial R-squared (SPRS) [80] and allowed us to compare the relative impact of each factor in the linear mixed effects model (Table S5). This method also allowed us to evaluate the fit for the whole model (SPRS = 0.368).

Data availability

All data generated or analysed during this study are included in this published article and its Supplementary Information files.

References

Kennan A, Aherne A, Humphries P. Light in retinitis pigmentosa. Trends Genet. 2005;21:103–10.
Article CAS PubMed Google Scholar
Narayan DS, Wood JP, Chidlow G, Casson RJ. A review of the mechanisms of cone degeneration in retinitis pigmentosa. Acta Ophthalmol. 2016;94:748–54.
Article PubMed Google Scholar
Hamel CP. Cone rod dystrophies. Orphanet J Rare Dis. 2007;2:7.
Article PubMed PubMed Central Google Scholar
Das S, Chen Y, Yan J, Christensen G, Belhadj S, Tolone A, et al. The role of cGMP-signalling and calcium-signalling in photoreceptor cell death: perspectives for therapy development. Pflug Arch. 2021;473:1411–21.
Article CAS Google Scholar
Barabas P, Cutler PC, Krizaj D. Do calcium channel blockers rescue dying photoreceptors in the Pde6b (rd1) mouse? Adv Exp Med Biol. 2010;664:491–9.
Article CAS PubMed PubMed Central Google Scholar
Wetzel RK, Arystarkhova E, Sweadner KJ. Cellular and subcellular specification of Na,K-ATPase α and β isoforms in the postnatal development of mouse retina. J Neurosci. 1999;19:9878–89.
Article CAS PubMed PubMed Central Google Scholar
Waldner DM, Bech-Hansen NT, Stell WK. Channeling vision: Ca(V)1.4-A critical link in retinal signal transmission. Biomed Res Int. 2018;2018:7272630.
Article CAS PubMed PubMed Central Google Scholar
Ingram NT, Sampath AP, Fain GL. Membrane conductances of mouse cone photoreceptors. J Gen Physiol. 2020;152:e201912520.
Article CAS PubMed PubMed Central Google Scholar
Paquet-Durand F, Beck S, Michalakis S, Goldmann T, Huber G, Muhlfriedel R, et al. A key role for cyclic nucleotide gated (CNG) channels in cGMP-related retinitis pigmentosa. Hum Mol Genet. 2011;20:941–7.
Article CAS PubMed Google Scholar
Fox DA, Poblenz AT, He LH. Calcium overload triggers rod photoreceptor apoptotic cell death in chemical-induced and inherited retinal degenerations. Ann Ny Acad Sci. 1999;893:282–5.
Article CAS PubMed Google Scholar
Vallazza-Deschamps G, Cia D, Gong J, Jellali A, Duboc A, Forster V, et al. Excessive activation of cyclic nucleotide-gated channels contributes to neuronal degeneration of photoreceptors. Eur J Neurosci. 2005;22:1013–22.
Article PubMed Google Scholar
Bowes C, Li T, Frankel WN, Danciger M, Coffin JM, Applebury ML, et al. Localization of a retroviral element within the rd gene coding for the beta subunit of cGMP phosphodiesterase. Proc Natl Acad Sci USA. 1993;90:2955–9.
Article CAS PubMed PubMed Central Google Scholar
Wei T, Schubert T, Paquet-Durand F, Tanimoto N, Chang L, Koeppen K, et al. Light-driven calcium signals in mouse cone photoreceptors. J Neurosci. 2012;32:6981–94.
Article CAS PubMed PubMed Central Google Scholar
Kulkarni M, Trifunovic D, Schubert T, Euler T, Paquet-Durand F. Calcium dynamics change in degenerating cone photoreceptors. Hum Mol Genet. 2016;25:3729–40.
Article CAS PubMed Google Scholar
Schon C, Paquet-Durand F, Michalakis S. Cav1.4 L-type calcium channels contribute to calpain activation in degenerating photoreceptors of rd1 mice. PLoS ONE. 2016;11:e0156974.
Article PubMed PubMed Central Google Scholar
Sothilingam V, Garcia-Garrido M, Jiao K, Buena-Atienza E, Sahaboglu A, Trifunovic D, et al. Retinitis Pigmentosa: Impact of different Pde6a point mutations on the disease phenotype. Hum Mol Genet. 2015;24:5486–99.
Article CAS PubMed Google Scholar
Hart J, Wilkinson MF, Kelly ME, Barnes S. Inhibitory action of diltiazem on voltage-gated calcium channels in cone photoreceptors. Exp Eye Res. 2003;76:597–604.
Article CAS PubMed Google Scholar
Stern JH, Kaupp UB, MacLeish PR. Control of the light-regulated current in rod photoreceptors by cyclic GMP, calcium, and l-cis-diltiazem. Proc Natl Acad Sci USA. 1986;83:1163–7.
Article CAS PubMed PubMed Central Google Scholar
Frasson M, Sahel JA, Fabre M, Simonutti M, Dreyfus H, Picaud S. Retinitis pigmentosa: rod photoreceptor rescue by a calcium-channel blocker in the rd mouse. Nat Med. 1999;5:1183–7.
Article CAS PubMed Google Scholar
Fox DA, Poblenz AT, He L, Harris JB, Medrano CJ. Pharmacological strategies to block rod photoreceptor apoptosis caused by calcium overload: a mechanistic target-site approach to neuroprotection. Eur J Ophthalmol. 2003;13:S44–56.
Article PubMed Google Scholar
Pawlyk BS, Sandberg MA, Berson EL. Effects of IBMX on the rod ERG of the isolated perfused cat eye: antagonism with light, calcium or L-cis-diltiazem. Vis Res. 1991;31:1093–7.
Article CAS PubMed Google Scholar
Pearce-Kelling SE, Aleman TS, Nickle A, Laties AM, Aguirre GD, Jacobson SG, et al. Calcium channel blocker D-cis-diltiazem does not slow retinal degeneration in the PDE6B mutant rcd1 canine model of retinitis pigmentosa. Mol Vis. 2001;7:42–7.
CAS PubMed Google Scholar
Pawlyk BS, Li T, Scimeca MS, Sandberg MA, Berson EL. Absence of photoreceptor rescue with D-cis-diltiazem in the rd mouse. Invest Ophthalmol Vis Sci. 2002;43:1912–5.
PubMed Google Scholar
Shuart NG, Haitin Y, Camp SS, Black KD, Zagotta WN. Molecular mechanism for 3:1 subunit stoichiometry of rod cyclic nucleotide-gated ion channels. Nat Commun. 2011;2:457.
Article PubMed Google Scholar
Peng C, Rich ED, Varnum MD. Subunit configuration of heteromeric cone cyclic nucleotide-gated channels. Neuron. 2004;42:401–10.
Article CAS PubMed Google Scholar
Cote RH, Brunnock MA. Intracellular cGMP concentration in rod photoreceptors is regulated by binding to high and moderate affinity cGMP binding sites. J Biol Chem. 1993;268:17190–8.
Article CAS PubMed Google Scholar
Nakatani K, Yau KW. Calcium and light adaptation in retinal rods and cones. Nature. 1988;334:69–71.
Article CAS PubMed Google Scholar
Frings S, Seifert R, Godde M, Kaupp UB. Profoundly different calcium permeation and blockage determine the specific function of distinct cyclic nucleotide-gated channels. Neuron. 1995;15:169–79.
Article CAS PubMed Google Scholar
Picones A, Korenbrot JI. Permeability and interaction of Ca2+ with cGMP-gated ion channels differ in retinal rod and cone photoreceptors. Biophys J. 1995;69:120–7.
Article CAS PubMed PubMed Central Google Scholar
Nache V, Eick T, Schulz E, Schmauder R, Benndorf K. Hysteresis of ligand binding in CNGA2 ion channels. Nat Commun. 2013;4:2866.
Article PubMed PubMed Central Google Scholar
Biskup C, Kusch J, Schulz E, Nache V, Schwede F, Lehmann F, et al. Relating ligand binding to activation gating in CNGA2 channels. Nature. 2007;446:440–3.
Article CAS PubMed Google Scholar
Nache V, Wongsamitkul N, Kusch J, Zimmer T, Schwede F, Benndorf K. Deciphering the function of the CNGB1b subunit in olfactory CNG channels. Sci Rep. 2016;6:29378.
Article PubMed PubMed Central Google Scholar
Arango-Gonzalez B, Trifunović D, Sahaboglu A, Kranz K, Michalakis S, Farinelli P, et al. Identification of a common non-apoptotic cell death mechanism in hereditary retinal degeneration. PLoS ONE. 2014;9:e112142.
Article PubMed PubMed Central Google Scholar
Powers TA, Rogin C. MarkeTrak 10: history and methodology. Semin Hear. 2020;41:3–5.
Article PubMed PubMed Central Google Scholar
Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995;376:37–43.
Article CAS PubMed Google Scholar
Vighi E, Trifunovic D, Veiga-Crespo P, Rentsch A, Hoffmann D, Sahaboglu A, et al. Combination of cGMP analogue and drug delivery system provides functional protection in hereditary retinal degeneration. Proc Natl Acad Sci USA. 2018;115:E2997–3006.
Article CAS PubMed PubMed Central Google Scholar
Bocchero U, Tam BM, Chiu CN, Torre V, Moritz OL. Electrophysiological changes during early steps of retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2019;60:933–43.
Article CAS PubMed Google Scholar
Haynes LW. Block of the cyclic GMP-gated channel of vertebrate rod and cone photoreceptors by l-cis-diltiazem. J Gen Physiol. 1992;100:783–801.
Article CAS PubMed Google Scholar
McLatchie LM, Matthews HR. Voltage-dependent block by L-cis-diltiazem of the cyclic GMP-activated conductance of salamander rods. Proc Biol Sci. 1992;247:113–9.
Article CAS PubMed Google Scholar
Tang L, Gamal El-Din TM, Lenaeus MJ, Zheng N, Catterall W. Structural basis for diltiazem block of a voltage-gated Ca2+ Channel. Mol Pharm. 2019;96:485–92.
Article CAS Google Scholar
Zhao Y, Huang G, Wu J, Wu Q, Gao S, Yan Z, et al. Molecular basis for ligand modulation of a mammalian voltage-gated Ca(2+) Channel. Cell. 2019;177:1495–.e12.
Article CAS PubMed Google Scholar
Zheng X, Fu Z, Su D, Zhang Y, Li M, Pan Y, et al. Mechanism of ligand activation of a eukaryotic cyclic nucleotide-gated channel. Nat Struct Mol Biol. 2020;27:625–34.
Article CAS PubMed PubMed Central Google Scholar
Xue J, Han Y, Zeng W, Wang Y, Jiang Y. Structural mechanisms of gating and selectivity of human rod CNGA1 channel. Neuron. 2021;109:1302–13.e4.
Article CAS PubMed Google Scholar
Fain GL, Lisman JE. Light, Ca2+, and photoreceptor death: new evidence for the equivalent-light hypothesis from arrestin knockout mice. Invest Ophthalmol Vis Sci. 1999;40:2770–2.
CAS PubMed Google Scholar
Olshevskaya EV, Ermilov AN, Dizhoor AM. Factors that affect regulation of cGMP synthesis in vertebrate photoreceptors and their genetic link to human retinal degeneration. Mol Cell Biochem. 2002;230:139–47.
Article CAS PubMed Google Scholar
Johnson JE Jr., Perkins GA, Giddabasappa A, Chaney S, Xiao W, White AD, et al. Spatiotemporal regulation of ATP and Ca2+ dynamics in vertebrate rod and cone ribbon synapses. Mol Vis. 2007;13:887–919.
CAS PubMed PubMed Central Google Scholar
Ames A III. Energy requirements of CNS cells as related to their function and to their vulnerability to ischemia: a commentary based on studies on retina. Can J Physiol Pharm. 1992;70:S158–64.
Article CAS Google Scholar
Wegierski T, Kuznicki J. Neuronal calcium signaling via store-operated channels in health and disease. Cell Calcium. 2018;74:102–11.
Article CAS PubMed Google Scholar
Johnson MT, Gudlur A, Zhang X, Xin P, Emrich SM, Yoast RE, et al. L-type Ca2+; channel blockers promote vascular remodeling through activation of STIM proteins. Proc Natl Acad Sci USA. 2020;117:17369.
Article CAS PubMed PubMed Central Google Scholar
Saraiva N, Prole DL, Carrara G, Johnson BF, Taylor CW, Parsons M, et al. hGAAP promotes cell adhesion and migration via the stimulation of store-operated Ca2+ entry and calpain 2. J Cell Biol. 2013;202:699–713.
Article CAS PubMed PubMed Central Google Scholar
Szikra T, Cusato K, Thoreson WB, Barabas P, Bartoletti TM, Krizaj D. Depletion of calcium stores regulates calcium influx and signal transmission in rod photoreceptors. J Physiol. 2008;586:4859–75.
Article CAS PubMed PubMed Central Google Scholar
Olshevskaya EV, Ermilov AN, Dizhoor AM. Factors that affect regulation of cGMP synthesis in vertebrate photoreceptors and their genetic link to human retinal degeneration. Mol Cell Biochem. 2002;230:139–47.
Article CAS PubMed Google Scholar
Paquet-Durand F, Hauck SM, van Veen T, Ueffing M, Ekström P. PKG activity causes photoreceptor cell death in two retinitis pigmentosa models. J Neurochem. 2009;108:796–810.
Article CAS PubMed Google Scholar
Power M, Das S, Schutze K, Marigo V, Ekstrom P, Paquet-Durand F. Cellular mechanisms of hereditary photoreceptor degeneration - Focus on cGMP. Prog Retin Eye Res. 2020;74:100772.
Article CAS PubMed Google Scholar
Roy A, Groten J, Marigo V, Tomar T, Hilhorst R. Identification of novel substrates for cGMP dependent Protein Kinase (PKG) through kinase activity profiling to understand its putative role in inherited retinal degeneration. Int J Mol Sci. 2021;22:1180.
Article CAS PubMed PubMed Central Google Scholar
Krizaj D, Copenhagen DR. Compartmentalization of calcium extrusion mechanisms in the outer and inner segments of photoreceptors. Neuron. 1998;21:249–56.
Article CAS PubMed PubMed Central Google Scholar
Spencer M, Detwiler PB, Bunt-Milam AH. Distribution of membrane proteins in mechanically dissociated retinal rods. Invest Ophthalmol Vis Sci. 1988;29:1012–20.
CAS PubMed Google Scholar
Koch S, Sothilingam V, Garcia Garrido M, Tanimoto N, Becirovic E, Koch F, et al. Gene therapy restores vision and delays degeneration in the CNGB1(−/−) mouse model of retinitis pigmentosa. Hum Mol Genet. 2012;21:4486–96.
Article CAS PubMed Google Scholar
Bareil C, Hamel CP, Delague V, Arnaud B, Demaille J, Claustres M. Segregation of a mutation in CNGB1 encoding the beta-subunit of the rod cGMP-gated channel in a family with autosomal recessive retinitis pigmentosa. Hum Genet. 2001;108:328–34.
Article CAS PubMed Google Scholar
Wissinger B, Gamer D, Jägle H, Giorda R, Marx T, Mayer S, et al. CNGA3 mutations in hereditary cone photoreceptor disorders. Am J Hum Genet. 2001;69:722–37.
Article CAS PubMed PubMed Central Google Scholar
Wutz K, Sauer C, Zrenner E, Lorenz B, Alitalo T, Broghammer M, et al. Thirty distinct CACNA1F mutations in 33 families with incomplete type of XLCSNB and Cacna1f expression profiling in mouse retina. Eur J Hum Genet. 2002;10:449–56.
Article CAS PubMed Google Scholar
Sanyal S, Bal AK. Comparative light and electron microscopic study of retinal histogenesis in normal and rd mutant mice. Z Anat Entwicklungsgesch. 1973;142:219–38.
Article CAS PubMed Google Scholar
Mank M, Reiff DF, Heim N, Friedrich MW, Borst A, Griesbeck O. A FRET-based calcium biosensor with fast signal kinetics and high fluorescence change. Biophys J. 2006;90:1790–6.
Article CAS PubMed Google Scholar
Kaupp UB, Niidome T, Tanabe T, Terada S, Bonigk W, Stuhmer W, et al. Primary structure and functional expression from complementary DNA of the rod photoreceptor cyclic GMP-gated channel. Nature. 1989;342:762–6.
Article CAS PubMed Google Scholar
Korschen HG, Illing M, Seifert R, Sesti F, Williams A, Gotzes S, et al. A 240 kDa protein represents the complete beta subunit of the cyclic nucleotide-gated channel from rod photoreceptor. Neuron. 1995;15:627–36.
Article CAS PubMed Google Scholar
Yu WP, Grunwald ME, Yau KW. Molecular cloning, functional expression and chromosomal localization of a human homolog of the cyclic nucleotide-gated ion channel of retinal cone photoreceptors. FEBS Lett. 1996;393:211–5.
Article CAS PubMed Google Scholar
Peng C, Rich ED, Thor CA, Varnum MD. Functionally important calmodulin-binding sites in both NH2- and COOH-terminal regions of the cone photoreceptor cyclic nucleotide-gated channel CNGB3 subunit. J Biol Chem. 2003;278:24617–23.
Article CAS PubMed Google Scholar
Liman ER, Tytgat J, Hess P. Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs. Neuron. 1992;9:861–71.
Article CAS PubMed Google Scholar
Shammat IM, Gordon SE. Stoichiometry and arrangement of subunits in rod cyclic nucleotide-gated channels. Neuron. 1999;23:809–19.
Article CAS PubMed Google Scholar
Jonas P. High-speed solution switching using piezo-based micropositioning stages. In: Sakmann B, Neher E (eds.). Single-channel recording. 2nd edn. (Plenum Press, New York, 1995) pp. xxii-700.
Thon S, Schulz E, Kusch J, Benndorf K. Conformational flip of nonactivated HCN2 channel subunits evoked by cyclic nucleotides. Biophys J. 2015;109:2268–76.
Article CAS PubMed PubMed Central Google Scholar
Zheng J & Zagotta WN. Patch-clamp fluorometry recording of conformational rearrangements of ion channels. Sci STKE. 2003;2003:PL7.
Nache V, Zimmer T, Wongsamitkul N, Schmauder R, Kusch J, Reinhardt L, et al. Differential regulation by cyclic nucleotides of the CNGA4 and CNGB1b subunits in olfactory cyclic nucleotide-gated channels. Sci Signal. 2012;5:ra48.
Article PubMed Google Scholar
Belhadj S, Tolone A, Christensen G, Das S, Chen Y, Paquet-Durand F. Long-term, serum-free cultivation of organotypic mouse retina explants with intact retinal pigment epithelium. J Vis Exp. 2020;165:e61868.
Google Scholar
Hair JF, Anderson RE, Tatham RL, Black W. Multivariate data analysis. (Macmillan, New York, 1995).
Nobre JS, da Motta Singer J. Residual analysis for linear mixed models. Biom J. 2007;49:863–75.
Article PubMed Google Scholar
Kulkarni M, Schubert T, Baden T, Wissinger B, Euler T, Paquet-Durand F. Imaging Ca2+ dynamics in cone photoreceptor axon terminals of the mouse retina. J Vis Exp. 2015;99:e52588.
Google Scholar
Euler T, Hausselt SE, Margolis DJ, Breuninger T, Castell X, Detwiler PB, et al. Eyecup scope-optical recordings of light stimulus-evoked fluorescence signals in the retina. Pflug Arch. 2009;457:1393–414.
Article CAS Google Scholar
Baden T, Schubert T, Chang L, Wei T, Zaichuk M, Wissinger B, et al. A tale of two retinal domains: near-optimal sampling of achromatic contrasts in natural scenes through asymmetric photoreceptor distribution. Neuron. 2013;80:1206–17.
Article CAS PubMed Google Scholar
Nakagawa S, Schielzeth H. A general and simple method for obtaining R2 from generalized linear mixed-effects models. Methods Ecol Evol. 2013;4:133–42.
Article Google Scholar

Download references

Acknowledgements

We thank N. Rieger from the Tübingen Institute for Ophthalmic Research as well as K. Schoknecht, S. Bernhardt, A. Kolchmeier from Institute of Physiology II (Jena) for technical assistance. We also thank J. Kusch and K. Benndorf (Institut of Physiology II, Jena) for excellent comments on the manuscript. This work was funded by the ProRetina Foundation the Charlotte and Tistou Kerstan Foundation and the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation; PA1751/7-1, 8-1 to FPD; EU42/8-1 to TE; TRR 166 ReceptorLight project B01 and Project Number 437036164 to VN). The authors declare no competing financial interests. FS is General Manager Operations and Head of R & D at Biolog Life Science Institute GmbH & Co. KG. FPD is Chief Scientific Officer for Mireca Medicines GmbH.

Author information

Authors and Affiliations

Institute for Ophthalmic Research, University of Tübingen, 72076, Tübingen, Germany
Soumyaparna Das, Michael Power, Jie Yan, Marlly Achury, Torsten Strasser, Thomas Euler & François Paquet-Durand
Institute of Physiology II, University Hospital Jena, Friedrich Schiller University Jena, 07743, Jena, Germany
Valerie Popp, Kathrin Groeneveld & Vasilica Nache
Werner Reichardt Centre for Integrative Neuroscience (CIN), University of Tübingen, 72076, Tübingen, Germany
Michael Power, Luke Rogerson & Thomas Euler
Biomolecular Photonics Group, University Hospital Jena, Friedrich Schiller University Jena, 07743, Jena, Germany
Kathrin Groeneveld & Christian Melle
BIOLOG Life Science Institute GmbH & Co KG, 28199, Bremen, Germany
Frank Schwede

Authors

Soumyaparna Das
View author publications
You can also search for this author in PubMed Google Scholar
Valerie Popp
View author publications
You can also search for this author in PubMed Google Scholar
Michael Power
View author publications
You can also search for this author in PubMed Google Scholar
Kathrin Groeneveld
View author publications
You can also search for this author in PubMed Google Scholar
Jie Yan
View author publications
You can also search for this author in PubMed Google Scholar
Christian Melle
View author publications
You can also search for this author in PubMed Google Scholar
Luke Rogerson
View author publications
You can also search for this author in PubMed Google Scholar
Marlly Achury
View author publications
You can also search for this author in PubMed Google Scholar
Frank Schwede
View author publications
You can also search for this author in PubMed Google Scholar
Torsten Strasser
View author publications
You can also search for this author in PubMed Google Scholar
Thomas Euler
View author publications
You can also search for this author in PubMed Google Scholar
François Paquet-Durand
View author publications
You can also search for this author in PubMed Google Scholar
Vasilica Nache
View author publications
You can also search for this author in PubMed Google Scholar

Contributions

SD performed retinal explant cultures, TUNEL and immunostaining, microscopy, analysed data and helped write the manuscript; MP performed Ca²⁺-imaging experiments; VP studied the effect of diltiazem on CNGC gating kinetics; KG performed colocalization experiments for heterotetrameric CNGCs; CM performed molecular-biology work; JY performed immunostaining; MA performed immunostaining and analysed data; LR analysed Ca²⁺-imaging data and performed statistical analysis; TS performed statistical analysis on immune- and bioassay data; FS synthesised fluorescent cGMP derivatives; VN performed electrophysiological and optical measurements to study the effect of diltiazem on CNGC; VN, TE and FPD designed the experiments, interpreted the data, and prepared the manuscript. All authors edited the manuscript.

Corresponding authors

Correspondence to François Paquet-Durand or Vasilica Nache.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Edited by Professor Gerry Melino

Supplementary information

Related Manuscript File

Supplementary material file-collated

Reproducibility checklist

Related File

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Cite this article

Das, S., Popp, V., Power, M. et al. Redefining the role of Ca²⁺-permeable channels in photoreceptor degeneration using diltiazem. Cell Death Dis 13, 47 (2022). https://doi.org/10.1038/s41419-021-04482-1

Download citation

Received: 23 April 2021
Revised: 07 October 2021
Accepted: 23 November 2021
Published: 10 January 2022
DOI: https://doi.org/10.1038/s41419-021-04482-1

This article is cited by

T-type voltage-gated channels, Na+/Ca2+-exchanger, and calpain-2 promote photoreceptor cell death in inherited retinal degeneration
- Jie Yan
- Lan Wang
- François Paquet-Durand
Cell Communication and Signaling (2024)